ListedSMEMAHALIFE

Mahamaya Lifesciences IPO

Mahamaya Lifesciences IPO is an SME IPO raising ₹70 Cr at ₹108 – ₹114 a share. It listed on 18 Nov 2025 at ₹116, +1.8% against its issue price of ₹114, and trades at ₹178 today (+55.9% since issue). It was subscribed 1.69× in total.

Get alerts on this company Company page Prospectus ↗

₹114

Issue price

₹178

Price now

+55.9%

Since issue price

18 Nov 2025

Listed on

1.69×Subscribed (final) · all exchanges

Just covered — bids slightly exceed the shares on offer

populated partly populated we hold nothing here — the tab says why

Terms of the issue

The mechanics of what is being sold. Held for every issue we track.

Price band₹108 – ₹114

Cut-off price₹114

Issue size₹70 Cr

Shares per lot1200

Minimum application₹1,36,800

Minimum quantity2400

Face value₹10

Listing exchangesBSE

ISININE0U9D01019

Bidding hours10:00 – 17:00 IST

Bidding window11 Nov 2025 – 13 Nov 2025

SME

What being an SME issue means here. SME issues list on NSE Emerge or BSE SME. They disclose less than mainboard issues, trade far more thinly, and — by regulation — the minimum application is a full lot worth roughly ₹1–1.5 lakh rather than about ₹15,000. That is why the minimum above is so much larger than for a mainboard issue.

Not here yet

Valuation against the issuer's named peers, what the fresh money funds, and the anchor-investor allocation come from reading the prospectus, which we do for current and upcoming issues — historical issues will not gain them.